Amgen launches an AbbVie Humira biosimilar in the US
Go back to Amgen launches an AbbVie Humira biosimilar in the US| AbbVie (NYSE: ABBV) | Delayed: 264.52 -0.44 (0.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $264.96 | 52 Week High | $68.12 | |||
| Open | $263.99 | 52 Week Low | $50.71 | |||
| Day High | $266.04 | P/E | 57.38 | |||
| Day Low | $262.07 | EPS | $4.61 | |||
| Volume | 3,813,099 | |||||
| Amgen Inc (NASDAQ: AMGN) | Delayed: 443.84 +4.51 (1.03%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $439.33 | 52 Week High | $176.85 | |||
| Open | $440.31 | 52 Week Low | $133.64 | |||
| Day High | $445.87 | P/E | 66.84 | |||
| Day Low | $435.51 | EPS | $6.64 | |||
| Volume | 2,372,294 | |||||
